Another Marker of Cardiac Dysfunction in Dialysis Patients?
Zoccali
Carmine
C
Istituto CNR di Biomedicina, Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Arteriosa, Reggio Calabria, Italy. Carmine.zoccali@tin.it
D015415:Biomarkers / Q000032:analysis; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000209:etiology*; D002352:Carrier Proteins / Q000032:analysis*; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D009206:Myocardium / Q000378:metabolism; D020097:Natriuretic Peptide, Brain / Q000032:analysis; D009363:Neoplasm Proteins; D006435:Renal Dialysis / Q000009:adverse effects*; D018570:Risk Assessment; D020107:Troponin T / Q000032:analysis; D025521:Tumor Suppressor Proteins
D015415:Biomarkers; D002352:Carrier Proteins; C107608:FABP7 protein, human; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D009363:Neoplasm Proteins; D020107:Troponin T; D025521:Tumor Suppressor Proteins; D020097:Natriuretic Peptide, Brain